SBIO vs. CNCR ETF Comparison

Comparison of ALPS Medical Breakthroughs ETF (SBIO) to Loncar Cancer Immunotherapy ETF (CNCR)
SBIO

ALPS Medical Breakthroughs ETF

SBIO Description

The investment seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the Poliwogg Medical Breakthroughs IndexSM. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small- and mid-cap stocks of biotechnology and pharmaceutical companies that have one or more drugs in either Phase II or Phase III U.S. Food and Drug Administration clinical trials. It is non-diversified.

Grade (RS Rating)

Last Trade

$47.23

Average Daily Volume

39,904

Number of Holdings *

101

* may have additional holdings in another (foreign) market
CNCR

Loncar Cancer Immunotherapy ETF

CNCR Description ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.

Grade (RS Rating)

Last Trade

$29.01

Average Daily Volume

6,604

Number of Holdings *

27

* may have additional holdings in another (foreign) market
Performance
SBIO CNCR
30 Days -11.70% -7.64%
60 Days -19.06% -12.28%
90 Days -16.99% -17.46%
12 Months 24.16% 23.18%
8 Overlapping Holdings
Grade Symbol Weight in SBIO Weight in CNCR Overlap
F BLUE 1.38% 2.46% 1.38%
D FATE 4.35% 3.1% 3.1%
D LEGN 2.63% 3.42% 2.63%
D MOR 2.1% 3.03% 2.1%
D RCUS 1.53% 4.15% 1.53%
F REPL 1.02% 2.57% 1.02%
F SRRK 1.29% 2.39% 1.29%
D XNCR 1.8% 3.66% 1.8%
SBIO Overweight 93 Positions Relative to CNCR
Grade Symbol Weight
D VIR 4.1%
F EBS 3.54%
F ARNA 3.0%
F CCXI 2.64%
F INSM 2.57%
F PTCT 2.56%
B AGIO 2.44%
D KRTX 2.4%
D SWTX 2.33%
C ALKS 2.27%
C APLS 2.27%
F FGEN 2.1%
D RCKT 2.1%
F GBT 1.82%
C VCEL 1.74%
D LGND 1.69%
F INO 1.37%
B MDGL 1.29%
F MCRB 1.28%
B DRNA 1.28%
B IRWD 1.25%
F SGMO 1.2%
B CYTK 1.17%
F AUPH 1.14%
F IMVT 1.12%
F RGNX 1.08%
F ZYME 1.07%
D ARQT 1.05%
D TVTX 1.05%
F ALVR 1.03%
D KRYS 1.0%
D ALEC 0.99%
F FMTX 0.98%
F QURE 0.98%
F CNST 0.82%
D RDUS 0.79%
F CHRS 0.78%
F AKRO 0.76%
C PRTA 0.74%
D CLDX 0.73%
F BTAI 0.72%
D CRTX 0.72%
D ENTA 0.71%
D VNDA 0.63%
F ADAP 0.58%
D KDNY 0.56%
F ESPR 0.55%
F ZIOP 0.54%
F ICPT 0.49%
F GOSS 0.49%
D CVM 0.48%
F VXRT 0.47%
F ALBO 0.45%
C MGTA 0.45%
B AFMD 0.44%
B XENE 0.43%
F MTEM 0.42%
D ACIU 0.41%
D EGRX 0.4%
D ANAB 0.4%
F XBIT 0.4%
F MIRM 0.4%
C CRNX 0.39%
D CMRX 0.39%
D ISEE 0.39%
F KNSA 0.39%
F SYRS 0.37%
F ALT 0.36%
F GERN 0.35%
D GMDA 0.35%
D SELB 0.34%
F AVRO 0.34%
C CPRX 0.33%
C ETNB 0.32%
F VKTX 0.31%
D ALDX 0.3%
C VSTM 0.29%
F PBYI 0.28%
D MEIP 0.28%
D CTMX 0.27%
C FBIO 0.25%
D KZR 0.22%
F IMUX 0.22%
C PRQR 0.21%
F FREQ 0.21%
F KMDA 0.2%
F NCNA 0.19%
F APTX 0.14%
F TARA 0.13%
F VYGR 0.13%
F CNCE 0.12%
F ASMB 0.11%
F APRE 0.08%
SBIO Underweight 19 Positions Relative to CNCR
Grade Symbol Weight
C IMAB -5.71%
B MGNX -5.21%
D BGNE -4.97%
D ALLO -4.4%
B BNTX -4.33%
F NKTR -4.2%
B GILD -4.09%
B BMY -4.04%
C REGN -3.89%
F ARGX -3.68%
C AZN -3.49%
D GMAB -3.37%
F CRSP -2.85%
F IGMS -2.32%
D IOVA -2.26%
F ATRA -2.04%
F ALXO -2.01%
F YMAB -1.87%
F NKTX -1.81%
Compare ETFs